Brief: Theravance Biopharma, Inc. Announces Enrollment Of First Patient In Yupelri® Phase 4 Study
10/01/2022 11:39
Jan 10 (Reuters) - Theravance Biopharma Inc TBPH.O :
* THERAVANCE BIOPHARMA, INC. ANNOUNCES ENROLLMENT OF FIRST PATIENT IN
YUPELRI®
PHASE 4 STUDY
Source text for Eikon: ID:nPnbBnsqKa
Further company coverage: TBPH.O
Recent news on Theravance Biopharma
See all newsTheravance Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ireland's Theravance Biopharma Q2 revenue rises 11% but misses estimates
Brief: Theravance Biopharma Q2 Operating Income USD -8.277 Million
Press Digest: Canada - June 30
Deals of the day-Mergers and acquisitions